<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="en"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Slovenian Medical Journal</journal-title>
            <trans-title-group xml:lang="sl">
               <trans-title>Zdravniški vestnik</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2523</article-id>
         <article-id pub-id-type="publisher-id">2523</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Cardiovascular system</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Original scientific article</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="en">
               <subject>Cardiovascular system</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="en"/>
            <alt-title alt-title-type="running-head" xml:lang="en">Survey of patients with iron deficiency anemia</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Cvejić Vidali</surname>
                  <given-names>Gaja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zver</surname>
                  <given-names>Samo</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
         </contrib-group>
         <aff id="aff1" xml:lang="en">
            <label>1</label>
            <institution>Department of Haematology, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Gaja Cvejić Vidali, e-mail: <email xlink:type="simple">gaja.vidali@gmail.com</email>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>6</month>
            <year>2018</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>6</month>
            <year>2018</year>
         </pub-date>
         <volume>87</volume>
         <issue>5–6</issue>
         <fpage>223</fpage>
         <lpage>36</lpage>
         <history>
            <date date-type="received">
               <day>28</day>
               <month>3</month>
               <year>2017</year>
            </date>
            <date date-type="accepted">
               <day>2</day>
               <month>3</month>
               <year>2018</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2018, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2018, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2018</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="en">
            <title>Abstract</title>
            <p>Background: Iron deficiency anaemia (IDA) is the most prevalent type of anaemia and a common cause for patient referrals to the haematology outpatient clinic. The aim of this study was to determine the number of patients with IDA treated at the Haematology Outpatient Clinic of the UMC Ljubljana in the period of two years, as well as to inquire into the causes for their referrals to the clinic, patient characteristics, their complete blood count results at initial examination, the prescribed therapy, the number and the causes of their follow-up visits. We draw special attention to the IDA onset mechanism, the microcytic anaemia therapy principles and the indications prompting a referral of an IDA patient to the haematology specialist.</p>
            <p>Methods: We undertook a retrospective analysis of the medical records of patients who were referred to the Haematology outpatient clinic of the UMC Ljubljana for examination in the two-year period between 1 January 2014 and 31 December 2015 and had been diagnosed with IDA on the basis of their clinical picture and their CBC values. Data were collected with the Hipokrat IT system and statistically evaluated with Microsoft Excel.</p>
            <p>Results: In the period relevant for our research, 277 patients of those who were referred to the Haematology outpatient clinic for medical examination were diagnosed with IDA. 11.6 % of these patients were male and 88.4 % female; 62.1 % of the female patients were of childbearing age. IDA was specified as the referral diagnosis in the cases of no more than 39 % of the patients referred to the specialist outpatient clinic, whilst the medical condition of the remaining percentage of patients was not identified by the referring doctor. Comorbidities were observed in 50.2 % of the patients, and for 62.5 % of the patients a follow-up appointment was scheduled by the treating haematologist. Of all patients, 63.5 % were treated with an intravenous iron preparation during their first examination at the outpatient clinic and a transfusion of erythrocytes was administered during such an examination to 4.3 % of the patients.</p>
            <p>Conclusion: Patients with IDA were often treated at our Haematology Outpatient Clinic in the relevant two-year period. The data indicates a poor recognition rate of this prevalent type of anaemia. IDA is not a blood disorder and the referral of IDA patients to the Haematology Outpatient Clinic is justified in the case of severe microcytic anaemia, when the patient does not respond to the oral or intravenous iron replacement therapy or if a concomitant change in the CBC persists despite the effective treatment with iron preparations.</p>
         </abstract>
         <kwd-group xml:lang="en">
            <kwd>iron deficiency anaemia</kwd>
            <kwd>microcytic anaemia</kwd>
            <kwd>anaemia of chronic disease</kwd>
            <kwd>hepcidin</kwd>
            <kwd>iron supplements</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Introduction">
         <label>1</label>
         <title>Introduction</title>
         <p>Iron-deficiency anemia (IDA) is the only anaemia that affects the wealthy and the poor alike. In the developed world it is more common in women of childbearing age with heavy menstrual bleeding (<xref ref-type="bibr" rid="b1">1</xref>). Its prevalence is higher in individuals taking non-steroid antirheumatic drugs and proton pump inhibitors, in the latter most probably because of ulcer disease and decreased gastric juice acidity (<xref ref-type="bibr" rid="b2">2</xref>). Inadequate nutrition only rarely causes iron-deficiency anaemia (IDA) in the developed world. However, it may occur in individuals following weird diets (<xref ref-type="bibr" rid="b1">1</xref>).The causes of IDA can be most bizarre: e.g. this form of anaemia is encountered in people with Munchausen syndrome (<xref ref-type="bibr" rid="b3">3</xref>). In the developing countries, it affects mostly children, adolescents and pregnant women as a result of inadequate nutrition and parasitic infections (<xref ref-type="bibr" rid="b1">1</xref>). In men and menopausal women diagnosed with IDA, the first step should be ruling out gastrointestinal cancer (<xref ref-type="bibr" rid="b4">4</xref>). Treating IDA patients with iron supplements is only a symptomatic measure. It is of key importance to discover and eliminate the cause of the disease. The paper reviews the results obtained over a two-year period for patients referred to the outpatient clinic of the Department of Haematology with the diagnosis of IDA and patients diagnosed with IDA on the basis of history, clinical and laboratory findings. The paper focuses on the recognition of IDA, identification of its causes, oral and intravenous iron supplementation and management of patients who fail to respond adequately to iron supplementation.</p>
      </sec>
      <sec id="s2" sec-type="Material and methods">
         <label>2</label>
         <title>Material and methods</title>
         <p>This retrospective analysis includes the records of 277 patients with the diagnosis of IDA referred to the outpatient clinic of the Department of Haematology between 1 January 2014 and 31 December 2015, including the patients who were diagnosed with IDA on the basis of clinical examination and laboratory tests done in the heamatology clinic. The analysis focused on patient age and gender, referral diagnosis, presence of symptoms and signs of anaemia, haemoglobin levels, erythrocyte levels, mean corpuscular volume (MCV), total iron binding capacity (TIBC), serum ferritin, concomitant blood changes and the presence of menopause in women. In addition, the associated chronic diseases and inflammations that could have led to the onset of anaemia of chronic disease were recorded. The data collected included the patient's comorbidities, inflammatory parameters, urea, uric acid and creatinine levels and liver enzymes. The number of patients scheduled for follow-up examination at the haematology outpatient clinic, the reason for control examination, the treatment modallity prescribed by the patient's GP prior to his/her attendance at the clinic, and the therapy was prescribed on the patient's first visit to the haematology outpatient clinic were also recorded. <table-wrap position="float" id="table1">
               <label>Tabela 1:</label>
               <caption>
                  <p> Classification of anaemias by Hb levels.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                     <col/>
                  </colgroup>
                  <thead>
                     <tr>
                        <th>Type of anaemia</th>
                        <th align="center">Hb levels</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td>mild</td>
                        <td>
                           <p>100–120 g/L (women)</p>
                           <p>100–130 g/L (men)</p>
                        </td>
                     </tr>
                     <tr>
                        <td>moderate</td>
                        <td align="right">70–100 g/L</td>
                     </tr>
                     <tr>
                        <td>severe</td>
                        <td align="right">&lt; 70 g/L</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
            <xref ref-type="table" rid="table1">Table 1</xref> presents the distribution of anaemias by haemoglobin levels. The data were collected using the Hipokrat computer-based information system and statistically evaluated with Microsoft Excel.</p>
         <table-wrap position="anchor" id="table2">
            <label>Table 2:</label>
            <caption>
               <p> Mean RBC indices and iron levels</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Laboratory parameters</th>
                     <th>Women</th>
                     <th>Men</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Mean Hg levels (g/L)</td>
                     <td>100,5 (σ = ± 20,4)</td>
                     <td>101,5 (σ = ± 23,3)</td>
                  </tr>
                  <tr>
                     <td>Mean RBC count (10<sup>12</sup>/L)</td>
                     <td>4,18 (σ = ± 0,62)</td>
                     <td>4,13 (σ = ± 0,95)</td>
                  </tr>
                  <tr>
                     <td>Mean serum iron levels (µmol/L)</td>
                     <td align="center" colspan="2">8,3 (σ = ± 10,9)</td>
                  </tr>
                  <tr>
                     <td>Mean ferritin levels (µg/L)</td>
                     <td align="center" colspan="2">21,6 (σ = ± 70,5)</td>
                  </tr>
                  <tr>
                     <td>Mean TIBC (µmol/L)</td>
                     <td align="center" colspan="2">71,3 (σ = ± 10,6)</td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <p>TIBC –total iron binding capacity; ơ- standard deviation (SD)</p>
            </table-wrap-foot>
         </table-wrap>
         <p>The following reference levels were used in the study:</p>
         <list>
            <list-item>
               <label>•</label>
               <p>Haemoglobin 120–160 g/L for women and 130–180 g/L for men (<xref ref-type="bibr" rid="b5">5</xref>)</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>Haematocrit 0.30–0.47 for women and 0.40–0.54 for men; MCV 82–98 fL; RBC 4,2–5,4 × 10<sup>12</sup>/L for women and 5,4–6,3 × 10<sup>12</sup>/L for men; WBC 3.9–11.1 × 10<sup>9</sup>/L; platelets 157–384 × 10<sup>9</sup>/L (<xref ref-type="bibr" rid="b6">6</xref>).</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>Serum iron:10.7–28.6 µmol/L; ferritin 10–120 µg/L for women and 20–300 µg/L for men; TIBC 44.8–80.6 µmol/L; increased CRP &gt; 5 mg/L; creatinine 44–97 µmol/L; elevated AST 3-fold the upper limit (0.52 µkat/L) for women and 3-fold the upper limit (0.58 µkat/L) for men; increased ALT 3-fold the upper limit (0.56 µkat/L) for women and 3-fold the upper limit (0.74 µkat/L) for men (<xref ref-type="bibr" rid="b7">7</xref>).</p>
            </list-item>
         </list>
         <p>The study was approved by the Medical Ethics Committee of the Republic of Slovenia on 14 Nov.2017 (no.0120–583/217/5).</p>
      </sec>
      <sec id="s3" sec-type="Results">
         <label>3</label>
         <title>Results</title>
         <p>The analysis included data for 277 patients seen for IDA at the outpatient clinic of the Department of Heamatology between 1 January 2014 and 31 December 2015. There were 32 men (11.6 %) and 245 women (88.4 %), of these 172 (62.1 %) were women of reproductive age and 73 ( 26.3 %) were menopausal women. The median age of men was 66.5 years (range 21–87 yrs) and the median age of women 44 years (range 18–94 yrs). <xref ref-type="table" rid="table2">Table 2</xref> shows mean RBC parameters. The majority of the referred patients had Hb levels in the range of mild or moderate anaemia. In slightly less than one fifth of the examined patients, Hb levels were within reference range. <xref ref-type="fig" rid="fig1">Figure 1</xref> indicates the classification of anaemias by Hb levels.</p>
         <p>Other referral diagnoses included: sweating, monoclonal spike, malaise, monoclonal immunoglobulin of undetermined significance, suspected myelodysplastic syndrome (MDS), suspected thalassemia, pancytopenia, chronic anaemia, macrocytosis, B12 deficiency, peripheral neuropathy, suspected haemolytic anaemia, positive Coombs test, jaundice and others.</p>
         <fig position="anchor" id="fig1">
            <label>Figure 1:</label>
            <caption>
               <p> Classification of anaemias by Hb level. N = 277</p>
            </caption>
            <p>
               <graphic xlink:href="2523-en-web-resources/image/zdravvestn-2523-en-01.png"/>
            </p>
         </fig>
         <p>Twelve patients (4.3 %) were referred to the clinic for an urgent exmination. One of these had mild, seven had moderate and six severe anemia.</p>
         <table-wrap position="anchor" id="table3">
            <label>Table 3:</label>
            <caption>
               <p> shows the most common GP referral diagnoses of patients diagnosed with IDA at the heamatology outpatient clinic.</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Referral diagnosis</th>
                     <th align="right">n = 277 (%)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Iron-deficiency anaemia</td>
                     <td align="right">108 (39)</td>
                  </tr>
                  <tr>
                     <td>Microcytic anaemia</td>
                     <td align="right">77 (27,8)</td>
                  </tr>
                  <tr>
                     <td>Anaemia</td>
                     <td align="right">30 (10,8)</td>
                  </tr>
                  <tr>
                     <td>Leukopenia</td>
                     <td align="right">5 (1,8)</td>
                  </tr>
                  <tr>
                     <td>Thrombocytopenia</td>
                     <td align="right">5 (1,8)</td>
                  </tr>
                  <tr>
                     <td>Iron deficiency</td>
                     <td align="right">4 (1,4)</td>
                  </tr>
                  <tr>
                     <td>Bicytopenia</td>
                     <td align="right">4 (1,4)</td>
                  </tr>
                  <tr>
                     <td>Normocytic anaemia</td>
                     <td align="right">4 (1,4)</td>
                  </tr>
                  <tr>
                     <td>Other diagnoses</td>
                     <td align="right">40 (14,6)</td>
                  </tr>
               </tbody>
            </table>
         </table-wrap>
         <p>On physical examination at the haematology outpatient clinic, pallor was the only sign of anaemia reported. It was documented in 145 (52.3 %) patients.</p>
         <p>
            <xref ref-type="table" rid="table4">Table 4</xref> shows that anaemia was frequently associated with other CBC changes.</p>
         <p>
            <xref ref-type="table" rid="table5">Table 5</xref> indicates that at least one concomitant condition was present in 139 referred patients (50.2 %).</p>
         <table-wrap position="anchor" id="table4">
            <label>Table 4:</label>
            <caption>
               <p> Classification of anaemias by concomitant changes in CBC</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Concomitant change in CBC</th>
                     <th align="right">n = 277 (%)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Leukopenia</td>
                     <td align="right">21 (7,6)</td>
                  </tr>
                  <tr>
                     <td>Leukocytosis</td>
                     <td align="right">16 (5,8)</td>
                  </tr>
                  <tr>
                     <td>Thrombocytopenia</td>
                     <td align="right">20 (7,2)</td>
                  </tr>
                  <tr>
                     <td>Thrombocytosis</td>
                     <td align="right">46 (16,6)</td>
                  </tr>
                  <tr>
                     <td>Pancytopenia</td>
                     <td align="right">4 (1,4)</td>
                  </tr>
               </tbody>
            </table>
         </table-wrap>
         <p>Three or more associated diseases were diagnosed in 35 (12.6 %) patients with IDA.</p>
         <table-wrap position="anchor" id="table5">
            <label>Table 5:</label>
            <caption>
               <p> Comorbidities in IDA patients</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Concomitant disease/condition</th>
                     <th align="right">n = 277 (%)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Type 2 diabetes</td>
                     <td align="right">23 (8,3)</td>
                  </tr>
                  <tr>
                     <td>Autoimmune disorder*</td>
                     <td align="right">23 (8,3)</td>
                  </tr>
                  <tr>
                     <td>Hypothyroidism</td>
                     <td align="right">18 (6,5)</td>
                  </tr>
                  <tr>
                     <td>Cancer</td>
                     <td align="right">8 (2,9)</td>
                  </tr>
                  <tr>
                     <td>Heart failure</td>
                     <td align="right">8 (2,9)</td>
                  </tr>
                  <tr>
                     <td>Occult GI bleeding</td>
                     <td align="right">6 (2,2)</td>
                  </tr>
                  <tr>
                     <td>Pregnancy</td>
                     <td align="right">5 (1,8)</td>
                  </tr>
                  <tr>
                     <td>Chronic renal failure</td>
                     <td align="right">3 (1,1)</td>
                  </tr>
                  <tr>
                     <td>Other</td>
                     <td align="right">69 (24,9)</td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <p>* ulcerative colitis, Chron's disease, rheumatoid arthritis, Hashimoto thyroiditis, coeliac disease, Sjögren syndrome, systemic sclerosis, type1 diabetes.</p>
            </table-wrap-foot>
         </table-wrap>
         <p>In the group of patients with a history of chronic diseases, 54 (19.5 %) patients had increased CRP, five (1.8 %) showed abnormal liver transaminase levels, and one female patient had elevated urea and creatinine levels. ACD associated with IDA was diagnosed in four female patients (1.4 %).</p>
         <p>A total of 173 (62.5 %) patients were scheduled for a follow-up appointment with the haematologist. Of these, 133 (48 %) attended for follow-up examination after iron supplementation.The haematologist ordered additional diagnostic procedures for IDA in 144 (52 %) cases.</p>
         <fig position="anchor" id="fig2">
            <label>Figure 2:</label>
            <caption>
               <p> Changes of laboratory patameters on the onset of negative iron balance.</p>
            </caption>
            <p>
               <graphic xlink:href="2523-en-web-resources/image/zdravvestn-2523-en-02.png"/>
            </p>
            <p>TIBC–total iron binding capacity; RDW–red cell distribution width. Source: Alleyne et al. (<xref ref-type="bibr" rid="b8">8</xref>).</p>
         </fig>
         <p>One hundred and sixty-three (58.8 %) patients had been treated for IDA in the past or were taking iron supplements at their first appointment at the clinic. Oral iron supplements were taken by 144 (52 %) patients; 30 (10.8 %) were treated by intravenous iron supplementation and nine (3.2 %) patients by transfusion of red cell concentrate (RCC). For the rest of the patients no data are available. Of all the patients examined, 210 (75.8 %) received treatment or instructions for treatment. Of these 176 (83.9 %) were treated with intravenous iron preparations, and 12 (5.5 %) with transfusion of RCC. Nine (30 %) patients who were given intravenous iron supplement at their first visit to the outpatient clinic received repeat dose of intravenous iron when seen at the haematology outpatient clinic. Fourty-one (28.5 %) patients initially treated with oral iron supplements continued to take iron per os after their follow-up examination. At follow-up examination, nine (2.9 %) patients received a transfusion of RCC.</p>
      </sec>
      <sec id="s4" sec-type="Discussion">
         <label>4</label>
         <title>Discussion</title>
         <p>IDA is the most common anaemia and is not regarded as a true blood disorder. The study showed that 277 patients with IDA – i.e.2.7 patients per day – were treated at the Department of Haematology over a 2-year period. There was a predominance of women of reproductive age. The most likely reason for anaemia in this population is menstrual blood loss.</p>
         <p>Absorption of iron is limited to 1 to 2 mg daily and most iron needed for erythropoiesis is provided through metabolic switch of macrophages that phagocytose senescent erythrocytes (<xref ref-type="bibr" rid="b1">1</xref>). In clinically significant iron deficiency, depletion of bodyiron stores is reflected in the blood by a decrease in serum ferritin levels (<xref ref-type="bibr" rid="b8">8</xref>). Depletion of iron stores leads to disturbances in haemoglobin synthesis and production of hypochromic microcytic erythrocytes in the bone marrow. As indicated by <xref ref-type="fig" rid="fig2">Figure 2</xref>, clinically significant forms of iron deficiency develop gradually.</p>
         <fig position="anchor" id="fig3">
            <label>Figure 3:</label>
            <caption>
               <p> The proposed diagnostic workup for microcytic anaemia</p>
            </caption>
            <p>
               <graphic xlink:href="2523-en-web-resources/image/zdravvestn-2523-en-03.png"/>
            </p>
            <p>MCV – mean corpuscular volume, RBC– red blood count, TIBC– total iron binding capacity.</p>
         </fig>
         <p>It is estimated that women of reproductive age lose 1 to 3 mg of iron daily; the intake of iron is often inadequate to maintain iron balance (<xref ref-type="bibr" rid="b1">1</xref>). In addition to heavy menstrual bleeding, the most common causes of IDA in the developed world include gastrointestinal bleeding, impaired iron absorption and unusual fad diets (<xref ref-type="bibr" rid="b1">1</xref>). In developing countries, IDA most commonly occurs as a result of poor nutrition in people living in poverty.</p>
         <p>In women with menorrhagia disorders of primary haemostasis should be considered (<xref ref-type="bibr" rid="b9">9</xref>). Von Willebrand disease affects approx.1 % of the general population and more than 5 % of women with menorrhagia (<xref ref-type="bibr" rid="b10">10</xref>). Women with heavy menstrual bleeding have a higher prevalence of abnormal platelet function (<xref ref-type="bibr" rid="b9">9</xref>). Further diagnostic testing in pre-menopausal women with IDA is the domain of a GP or a gynaecologist. Even in young women IDA may be brought about by occult gastrointestinal bleeding. Screening for blood in the stool should be done at least six times in a row (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
         <p>One-third of the IDA patients seen in the haematology outpatient clinic were older males and menopausal females in whom IDA is very likely due to gastrointestinal diseases (<xref ref-type="bibr" rid="b1">1</xref>). Gastrointestinal diagnostic testing in this population is imperative (<xref ref-type="bibr" rid="b4">4</xref>). Endoscopic procedures are done to rule out gastrointestinal malignancies, mucosal inflammation, ulcers and angiodysplasia (<xref ref-type="bibr" rid="b1">1</xref>). Another cause of IDA may be haemorrhoidal bleeding. After ruling out gastrointestinal haemorrhage, impaired iron absorption that may be due to <italic>Heliobacter pylori</italic> infection, coeliac disease and chronic inflammatory bowel diseases should be considered in all age groups. IDA due to bleeding in the urinary tract is rare. History of unusual dietary patterns and medication should be reviewed in both sexes (<xref ref-type="bibr" rid="b11">11</xref>). IDA may occur as a result of the therapy with non-steroid anti-rheumatic drugs, salicylates, warfarin, clopidogrel, heparin, glucocorticoids and proton pump inhibitors (<xref ref-type="bibr" rid="b1">1</xref>). Anaemia is a symptom rather than a disease and it is necessary to determine its aetiology.</p>
         <table-wrap position="anchor" id="table6">
            <label>Table 6:</label>
            <caption>
               <p> Oral iron preparations for the treatment of IDA</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Brand name</th>
                     <th>Substance</th>
                     <th>Packaging</th>
                     <th>Dosage*</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Ferrum Lek®</td>
                     <td>trivalent iron oxide</td>
                     <td>
                        <p>30 × 100 mg</p>
                        <p>chewable tablets</p>
                        <p>100 ml of syrup</p>
                        <p>50 mg/5 ml</p>
                     </td>
                     <td>
                        <p>1–3 tbs/day</p>
                        <p>10–30 ml/day</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Eisensulfat</p>
                        <p>Lomapharm®</p>
                     </td>
                     <td>two-valent ferrous sulphate</td>
                     <td>
                        <p>20 x, 50x, 100x</p>
                        <p>100 mg tablets</p>
                     </td>
                     <td>1 tb/12 hours</td>
                  </tr>
                  <tr>
                     <td>Legofer®</td>
                     <td>trivalent iron proteinsukcinalat</td>
                     <td>
                        <p>150 ml of syrup</p>
                        <p>40 mg/15 ml</p>
                     </td>
                     <td>7.5–15 ml/12 hours</td>
                  </tr>
                  <tr>
                     <td>Tardyfer®</td>
                     <td>two-valent iron sulphate</td>
                     <td>30 × 80 mg tablets</td>
                     <td>1–2 tbs/day</td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <p>* dosage for adults with overt iron deficiency</p>
            </table-wrap-foot>
         </table-wrap>
         <p>As indicated by <xref ref-type="table" rid="table3">Table 3</xref> mean Hb levels in the men and women studied bordered between mild and moderate anaemia. Mean serum iron concentration was expectedly decreased, mean serum ferritin was at the lower border of normal and mean TIBC was within the range of reference levels. Interestingly, nearly one-fifth of the patients had normal Hb levels at their first appointment at the haematology outpatient clinic, which may be explained by the fact that the triage haematologist gives treatment instructions based on the enclosed laboratory results to the patient's GP prior to his/her examination at the clinic.</p>
         <p>A surprisingly large proportion of patients in the study were referred as urgent cases. In half of them, Hb levels were within the range of moderate anaemia and in one female patient they were even suggestive of mild anaemia.</p>
         <p>
            <xref ref-type="table" rid="table4">Table 4</xref> shows that a little less than half of the patients were referred to the haematology outpatient clinic with the diagnosis of IDA. In only one-tenth Hb levels were within the range of severe anaemia. Indications for referral of IDA patients to the haematologist included: severe macrocytic anaemia (Hb &lt; 70 g/L), unclear differentiation of IDA from ACD and other abnormalities in CBC that persist despite iron supplementation and increase in the Hb levels.</p>
         <table-wrap position="anchor" id="table7">
            <label>Table 7:</label>
            <caption>
               <p> Intravenous iron preparations for the treatment of IDA</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Brand name</th>
                     <th>Substance and carrier</th>
                     <th>Packaging</th>
                     <th>Dosage*</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Ferrologic®</td>
                     <td>trivalent iron oxide (saccharated)</td>
                     <td>
                        <p>20 mg/ml</p>
                        <p>5-ml ampoules</p>
                     </td>
                     <td>100–200 mg/day to 3 times a week, or max.500 mg once a week</td>
                  </tr>
                  <tr>
                     <td>Iroprem®</td>
                     <td>trivalent iron carboxymaltose</td>
                     <td>
                        <p>50 mg/ml</p>
                        <p>10-ml vials</p>
                        <p>2-ml vials</p>
                     </td>
                     <td>
                        <p>max.1000 mg/day</p>
                        <p>once a week</p>
                     </td>
                  </tr>
                  <tr>
                     <td>Venofer®</td>
                     <td>Trivalent iron oxide (saccharated)</td>
                     <td>
                        <p>20 mg/ml</p>
                        <p>5-ml ampoules</p>
                     </td>
                     <td>
                        <p>100–200 mg/day to</p>
                        <p>3 times a week or max.500 mg once a week</p>
                     </td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <p>*total cummulative dose of IV iron is calculated as follows:</p>
               <p>Ferrologic® and Venofer®</p>
               <p>Total amount of iron to be administered (mg) = body mass (kg) x (target Hg concentration – actual Hb concentration (g/l) × 0.24* + amount of iron needed to fill up body iron stores (500 mg)</p>
               <p>Iroprem®</p>
               <p>Patients with BMI 35 kg to &lt; 70 kg; Hb &lt; 10 g/dl: 1,500 mg, Hb ≥ 10 g/dl: 1,000 mg</p>
               <p>Patients with BMI ≥ 70 kg; Hb &lt; 10 g/dl: 2,000 mg, Hb ≥ 10 g/dl: 1,500 mg.</p>
            </table-wrap-foot>
         </table-wrap>
         <p>IDA remains a condition with low recognition rate. As many as one-third of patients were referred to the clinic with the diagnosis of microcytic anaemia, which is surprising considering the fact that IDA is known to be by far the most common cause of microcytic anaemia. In addition to low Hb levels and the associated microcytosis, the evidence of reduced body's iron stores (decreased serum iron and decreased serum ferritin levels) is necessary to confirm the diagnosis of IDA (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b11">11</xref>). MCV is considered a nonspecific index as the presence of normocytic anaemia does not exclude iron deficiency (<xref ref-type="bibr" rid="b12">12</xref>). A combination of IDA and vitamin B12 or folate deficiency should also be considered. In addition to IDA, the differential diagnosis of microcytic anaemia should include ACD and thalassemia minor (<xref ref-type="bibr" rid="b11">11</xref>).</p>
         <p>ACD is a form of anaemia seen in chronic diseases, chronic infection, chronic inflammation and malignancy (<xref ref-type="bibr" rid="b11">11</xref>). It is characterised by elevated levels of the hormone hepcidin, which inhibits intestinal iron absorption and release of iron from body iron stores. Laboratory findings therefore include low serum iron, elevated serum ferritin and, frequently, decreased TIBC concentration. Serum ferritin is not a relevant parameter in the assessment of body iron stores in ACD (<xref ref-type="bibr" rid="b13">13</xref>).</p>
         <p>Beta thalassemia minor is the most common haemoglobinopathy in Slovenia (<xref ref-type="bibr" rid="b14">14</xref>). It affects mostly individuals with Mediterranean and Balkan ancestors. In the future its prevalence is likely to increase with international migration flows. Patients with beta thalassemia minor, as a rule, experience no clinical symptoms. They have mild anaemia (Hb levels of around 100 g/L) pronounced microcytosis (MCV of 60–70 fl) and normal RBC count (<xref ref-type="bibr" rid="b15">15</xref>). Typically, there is a disproportion between Hb levels and pronounced microcytosis. Examination of the peripheral blood smear reveals target erythrocytes and basophilic punctation of erythrocytes, with prevailing dacriocytes and ovalocytes (<xref ref-type="bibr" rid="b16">16</xref>). In patients with suspected thalassemia minor, haemoglobin electrophoresis is used instead of unpleasant endoscopic examinations to confirm abnormal findings.</p>
         <p>Once the diagnosis of microcytic anaemia is made, the patient's body iron status, i.e serum iron, serum ferritin and TIBC levels, should be determined (<xref ref-type="bibr" rid="b11">11</xref>). Patients with IDA have low serum iron and serum ferritin and high TIBC concentrations. Reduced ferritin is the most reliable parameter used to confirm IDA (<xref ref-type="bibr" rid="b17">17</xref>). Normal ferritin levels in the serum with concurrent low serum iron levels do not rule out IDA, as IDA may be associated with ACD (<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b13">13</xref>).</p>
         <p>Iron homeostasis is a process regulated mainly by hepcidin, a hormone present in the liver (<xref ref-type="bibr" rid="b11">11</xref>). Elevated plasma levels of iron induce secretion of hepcidin from the liver. By binding to the transmembrane iron transporter ferroportin it causes its degradation and thereby inhibits iron release from the duodenum and delivery from the reticuloendothelial system in the blood. Chronic inflammations and infections enhance hepcidin secretion from the liver and reduce the levels of serum iron, which is stored in adequate amounts in the body. The condition is known as functional iron deficiency. It is differentiated from manifested iron deficiency by high levels of storage iron, confirmed by high serum ferritin concentration.</p>
         <p>As concluded by clinical studies, patients with chronic diseases have iron deficiency when their ferritin levels drop below 100 µg/L (<xref ref-type="bibr" rid="b18">18</xref>). There is, however, some discrepancy between the authors. According to some investigators (<xref ref-type="bibr" rid="b2">2</xref>,<xref ref-type="bibr" rid="b19">19</xref>) ferritin concentration associated with iron deficiency is 200 µg/L. Final recommendations are still awaited. In Slovenia, patients with ACD are treated with iron supplements when their ferritin levels drop below 100 µg/L. These patients do not respond to oral iron replacement, therefore invariably intravenous therapy is used (<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b20">20</xref>).</p>
         <p>One-third of the patients studied presented with concomitant chronic diseases. The laboratory parameters that help us determine the combined aetiology of microcytic anaemia include: transferrin saturation, soluble transferrin receptor levels, reticulocyte haemoglobin content and hepcidin levels (<xref ref-type="bibr" rid="b19">19</xref>). It is possible to measure those parameters in the laboratory of the Department of Haematology but are not routinely done.</p>
         <p>Low serum iron levels indicate iron deficiency. Serum iron, however, is not a reliable index of body iron stores because of the role played by the individual's diet. After patient with IDA ingest food high in iron, serum iron can rise. Misled by these results, the physician may assume that the patient's iron stores are adequate, yet in the absence of ACD, low ferritin concentration are the key index of the body's stores of iron. Because of fluctuations caused by diurnal variation, serum iron levels are the highest in the morning and at noon, and decrease gradually in the afternoon (<xref ref-type="bibr" rid="b21">21</xref>). Iron is an ideal food source for microorganisms, therefore individuals with high levels of serum iron are prone to infections and septic conditions (<xref ref-type="bibr" rid="b35">35</xref>,<xref ref-type="bibr" rid="b36">36</xref>).</p>
         <p>Patients who present to the haematology outpatient clinic often provide results of blood tests and serum iron determination without data of serum ferirtin concentration. This information is of key importance in the management of patients with IDA and should therefore always be included in the patient's referral medical documentation.</p>
         <p>Clinical presentation of anaemia is well known, but it is of primary importance to obtain information on the speed of onset of the disease. Patients with chronic anaemia, even those with severe microcytic anaemia, are often free of symptoms. The authors have experience in treating Jehowah's Witnesses who attended for follow-up examinations until their Hb levels were less than 40 g/L. Pallor was documented in only half of the study patients seen in the haematology clinic. It is a matter of the haematologist's subjective judgement. This sign is only rarely mentioned in the patient's record. Haematologists, faced with overcrowded waiting rooms, work fast and may therefore be inaccurate. Iron replacement therapy is instituted also in patients who complain of severe fatigue, exertional dyspnea and palpitations.</p>
         <p>
            <xref ref-type="table" rid="table4">Table 4</xref> shows that many study patients with anaemia had concomitant CBC abnormalities. IDA is often accompanied with changes of CBC (<xref ref-type="bibr" rid="b22">22</xref>), the most common being reactive thrombocytosis. It was present in one-sixth of the study patients. The exact causative mechanism of reactive thrombocytosis in patients with IDA is unknown (<xref ref-type="bibr" rid="b23">23</xref>). Some studies explain it as a synergistic effect of erythropoeitin on platelet formation (<xref ref-type="bibr" rid="b24">24</xref>). It makes sense that patients presenting with anaemia and thrombocytosis have a peripheral smear test to rule out the presence of IDA. According to the literature data reactive leukopenia is encountered in 2–17 % of IDA patients (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>). It tends to be mild with iron levels of 3.0 × 10<sup>9</sup>/L or higher (<xref ref-type="bibr" rid="b22">22</xref>). In this review, leukopenia was recorded in 7 % of cases. A similar proportion of patients had thrombocytopenia, which, according to the literature, is less frequently associated with IDA (<xref ref-type="bibr" rid="b27">27</xref>,<xref ref-type="bibr" rid="b28">28</xref>). In patients with a combination of anaemia and thrombocytopenia it is necessary to consider thrombotic microangiopathy or any of its forms, such as thrombotic thrombocytopenic purpura and haemolytic uremic syndrome, chracterised by typical clinical manifestations and abnormal laboratory findings. A few cases of pancytopenia have been documented, yet the disorder rarely occurs in patients with IDA (<xref ref-type="bibr" rid="b29">29</xref>). Low counts of all blood cells are more often found in megaloblastic anaemia (<xref ref-type="bibr" rid="b30">30</xref>). Iron supplementation usually makes all the aforementioned changes in CBC disappear. If IDA goes away but other abnormal CBC findings persist, the patient needs further haematologic evaluation to exclude possible concomitant blood disorders (<xref ref-type="bibr" rid="b22">22</xref>).</p>
         <p>A surprisingly large number of patients were invited to attend for a follow-up examination, in our opinion, the majority of them for no clear reason. Following a patient with IDA is the domain of the patient's GP.</p>
         <p>Prior to their visit to the haematology outpatient clinic more than half of the patients were taking iron supplements. IDA is invariably treated with iron replacement. Oral iron is the first-choice treatment for haemodynamically stable IDA patients (<xref ref-type="bibr" rid="b1">1</xref>). The recommended dosage for adult patients is 200 mg divided into morning and evening doses. The duration of iron replacement therapy is three months. Haemoglobin levels are expected to increase by 20 g/L over three weeks ( 1 g/L daily) (<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b31">31</xref>). In order to fill up iron stores, treatment with iron supplements at a dose of 100 mg daily is continued for further three to six months (<xref ref-type="bibr" rid="b32">32</xref>).</p>
         <p>For better iron absorption iron supplements should be taken on an empty stomach or at least two hours after meals, together with vitamin C (<xref ref-type="bibr" rid="b1">1</xref>). Some authors recommend taking iron supplements with a meat-based meal (<xref ref-type="bibr" rid="b11">11</xref>). Iron absorption is impaired by a simultaneous ingestion of calcium (milk and dairy products), tannin (black tea, some herbal teas, red wine), phytates (cereals, grains) and caffeine (<xref ref-type="bibr" rid="b33">33</xref>).</p>
         <p>Gastrointestinal problems that may be caused by iron supplements are the most common reason for unsuccessful therapy (<xref ref-type="bibr" rid="b11">11</xref>). Taking iron on a regular basis is more important for the effective therapy than the choice between two- and three-valent iron supplements (<xref ref-type="bibr" rid="b1">1</xref>). Some manufacturers recommend slow-release formulations, yet from these preparations iron is released in the digestive tract distal to the duodenum where no absorption takes place (<xref ref-type="bibr" rid="b1">1</xref>). The principal site for iron absorption if the upper gastrointestinal tract, i.e. in the upper half of the duodenum. Side-effects of therapy are therefore more pronounced. Iron supplements cause black stools, yet faecal occult blood tests are negative (<xref ref-type="bibr" rid="b1">1</xref>).</p>
         <p>The newer understanding of the role of hepcidin has led to changes in the treatment with oral supplements. Recent studies showed that a single daily dose of iron increases hepcidin levels in blood and decreases absorption of iron from subsequent doses. The effect of hepcidin may be apparent for up to 48 hours (<xref ref-type="bibr" rid="b37">37</xref>). The present recommended dosing scheme will probably be a single daily dose of iron supplement taken on alternate days (<xref ref-type="bibr" rid="b38">38</xref>). Further clinical research are needed in this field. Currently, standard dosing of oral iron is recommended as described in this paper.</p>
         <p>If a 4- to 6-week treatment with elemental iron of 100 mg daily fails to increase haemoglobin levels by 10 g/L, the diagnosis of refractory IDA is made (<xref ref-type="bibr" rid="b20">20</xref>). Common causes of refractory IDA include: coeliac disease, autoimmune atrophic gastritis, gastritis caused by <italic>H.pylori</italic> infection and iron refractory iron deficiency anaemia (IRIDA), a hereditary form of IDA (<xref ref-type="bibr" rid="b20">20</xref>). IDA is the most common extraintestinal manifestation of coeliac disease. It occurs as a result of a combination of impaired iron absorption and occult bleedings (<xref ref-type="bibr" rid="b20">20</xref>). Gastric hypoacidity in autoimmune atrophic gastritis impairs oral iron solubility (<xref ref-type="bibr" rid="b20">20</xref>). Clinical studies have confirmed the connection between refractory IDA and gastritis caused by <italic>H.pylori</italic> infection. A clear mechanism behind the effect of this microorganism on iron uptake, occult bleedings and gastric juice alkalisation is yet unknown (<xref ref-type="bibr" rid="b20">20</xref>). Eradication of <italic>H.pylori</italic> infection and simultaneous iron replacement therapy have proved effective in treating IDA in most cases (<xref ref-type="bibr" rid="b34">34</xref>). IRIDA is a rare hereditary condition caused by mutations in TMPRSS6 gene which encodes matriptase 2 enzyme (<xref ref-type="bibr" rid="b1">1</xref>), affecting the regulation of hepcidin secretion. This disease is characterised by very high hepcidin levels that impair absorption of iron from the digestive tract. Iron status in hypochromic microcytic anaemia in similar to that in ACD: serum iron levels are very low, while serum ferritin is normal or even elevated. Absence of inflammatory signs differentiates it from ACD. It affects more commonly children and young adults.</p>
         <p>Indications for intravenous iron therapy include: intolerance of iron preparations, refractory anaemia associated with iron deficiency, refusal of transfusion based on religious reasons (Jehovah's Witnesses), filling up of iron stores before treatment with erythropoieitin (<xref ref-type="bibr" rid="b1">1</xref>). Intravenous iron therapy causes a fast increase in iron serum haemoglobin and is therefore used in IDA patients scheduled for surgery, as well as in women in the second and third month of pregnancy with severe anaemia, and in patients with blood coagulation disorders bleeding from the gastrointestinal tract. Fear of allergic reactions to intravenous iron administration comes from the past when dextran-containing iron preparations were used for intravenous iron replacement (<xref ref-type="bibr" rid="b39">39</xref>). Dextran was most often responsible for adverse reactions in these patients. Iron supplements used today contain no dextran and allergic reactions are very rare. Giving the patient intravenous iron supplements in the health care centre is an entirely safe procedure, therefore referral to the haematologist is not justified (<xref ref-type="bibr" rid="b40">40</xref>). Costs of treatment are covered under the national health insurance scheme. Intravenous iron replacement in the first trimester of pregnancy is avoided because of a lack of safety studies (<xref ref-type="bibr" rid="b40">40</xref>).</p>
         <p>Transfusion of red cell concentrates (RCC) in IDA is symtpomatic and should be reserved for patients with severe clinical problems (<xref ref-type="bibr" rid="b1">1</xref>). RCC transfusion is beneficial for healthy individuals with haemoglobin concentrations below 60 g/L. Anaemia is not well tolerated by patients with heart disease; cardiac patients with haemoglobin concentration of less than 100 g/L had higher mortality rates (<xref ref-type="bibr" rid="b41">41</xref>). RCC transfusion is usually given after acute bleeding regardless of the site of bleeding. Also, it is administered to patients with major chronic haemorrhage in whom haematopoesis cannot compensate for blood loss, i.e. patients with hereditary haemorrhagic telangiectasia (<xref ref-type="bibr" rid="b1">1</xref>). RCC transfusion is indicated in patients with heart failure and chronic renal or liver diseases, and in patients with other chronic conditions who have a higher threshold for transfusion, dependent on symptoms and signs of anaemia. RCC transfusion always worsens the course and outcome of treatment of primary disease.</p>
         <p>In patients receiving RCC transfusion, iron supplementation should be instituted, as a rule, via the intravenous route (<xref ref-type="bibr" rid="b42">42</xref>). Erythropoietin has no place in the treatment of IDA.</p>
         <p>Iron supplements used in IDA patients in Slovenia (<xref ref-type="bibr" rid="b43">43</xref>):</p>
         <list>
            <list-item>
               <label>•</label>
               <p>Oral iron supplements are listed in <xref ref-type="table" rid="table6">Table 6</xref>.</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>Intravenous iron preparations are listed in <xref ref-type="table" rid="table7">Table 7</xref>
               </p>
            </list-item>
         </list>
      </sec>
      <sec id="s5" sec-type="Conclusion">
         <label>5</label>
         <title>Conclusion</title>
         <p>IDA is a common reason for referring patients to the haematology outpatient clinic. The results of this study show that most of the patients seen in the clinic were women of childbearing age. The majority of patients with IDA received intravenous iron replacement. The results indicate that microcytic anaemia is a condition with low recognition rate. Referral to the haematology outpatient clinic is justified if the patient has severe symptomatic microcytic anaemia (Hb &lt; 70 g/L) or if concomitant changes in the CBC persist despite iron supplementation and with increase in Hb levels.</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <ref id="b1">
            <label>1. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Camaschella</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Iron-deficiency anemia</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2015</year>
                    <month>May</month>;
                    <volume>372</volume>(
                    <issue>19</issue>):
                    <fpage>1832</fpage>–
                    <lpage>43</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMra1401038</pub-id>
                    <pub-id pub-id-type="pmid">25946282</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <label>2. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Short</surname>
                     <given-names>MW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Domagalski</surname>
                     <given-names>JE</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Iron deficiency anemia: evaluation and management</article-title>. 
                    <source>Am Fam Physician</source>. 
                    <year>2013</year>
                    <month>Jan</month>;
                    <volume>87</volume>(
                    <issue>2</issue>):
                    <fpage>98</fpage>–
                    <lpage>104</lpage>.
                    <pub-id pub-id-type="pmid">23317073</pub-id>
                    <issn>1532-0650</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <label>3. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Nishimura</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Matsuzaki</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fujimoto</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kawakita</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Takatsuki</surname>
                     <given-names>K</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Münchhausen syndrome with severe iron deficiency anemia</article-title>. 
                    <source>Rinsho Ketsueki</source>. 
                    <year>1992</year>
                    <month>Apr</month>;
                    <volume>33</volume>(
                    <issue>4</issue>):
                    <fpage>478</fpage>–
                    <lpage>82</lpage>.
                    <pub-id pub-id-type="pmid">1602612</pub-id>
                    <issn>0485-1439</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <label>4. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Khadem</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Scott</surname>
                     <given-names>IA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Klein</surname>
                     <given-names>K</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Evaluation of iron deficiency anaemia in tertiary hospital settings: room for improvement?</article-title>
                    <source>Intern Med J</source>. 
                    <year>2012</year>
                    <month>Jun</month>;
                    <volume>42</volume>(
                    <issue>6</issue>):
                    <fpage>658</fpage>–
                    <lpage>64</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1445-5994.2012.02724.x</pub-id>
                    <pub-id pub-id-type="pmid">22288902</pub-id>
                    <issn>1444-0903</issn>
                </mixed-citation>
         </ref>
         <ref id="b5">
            <label>5. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>World Health Organ</collab>
                    </person-group>. 
                    <source>Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity</source>.
                    <publisher-loc>Geneva</publisher-loc>:
                    <publisher-name>WHO</publisher-name>;
                    <year>2011</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-01-10">cited 2017 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.who.int/vmnis/indicators/haemoglobin.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b6">
            <label>6. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Laboratorijski vodnik UKC Ljubljana, INTKOHem- Interna klinika - KO za hematologijo-Specializirani hematološki laboratorij</source>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-01-10">cited 2017 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://lab.biarti.si/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b7">
            <label>7. </label>
            <mixed-citation publication-type="webpage">
                <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <source>Laboratorijski vodnik UKC Ljubljana, KIKKB Klinični inštitut za klinično kemijo in biokemijo</source>. 
                [<date-in-citation content-type="access-date" iso-8601-date="2017-01-10">cited 2017 Jan 10</date-in-citation>].
                </mixed-citation>
         </ref>
         <ref id="b8">
            <label>8. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Alleyne</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Horne</surname>
                     <given-names>MK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Miller</surname>
                     <given-names>JL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Individualized treatment for iron-deficiency anemia in adults</article-title>. 
                    <source>Am J Med</source>. 
                    <year>2008</year>
                    <month>Nov</month>;
                    <volume>121</volume>(
                    <issue>11</issue>):
                    <fpage>943</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.amjmed.2008.07.012</pub-id>
                    <pub-id pub-id-type="pmid">18954837</pub-id>
                    <issn>0002-9343</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <label>9. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Mills</surname>
                     <given-names>HL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Abdel-Baki</surname>
                     <given-names>MS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Teruya</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dietrich</surname>
                     <given-names>JE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Shah</surname>
                     <given-names>MD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mahoney</surname>
                     <given-names>D</given-names>
                     <suffix>Jr</suffix>
                  </name>
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Platelet function defects in adolescents with heavy menstrual bleeding</article-title>. 
                    <source>Haemophilia</source>. 
                    <year>2014</year>
                    <month>Mar</month>;
                    <volume>20</volume>(
                    <issue>2</issue>):
                    <fpage>249</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/hae.12293</pub-id>
                    <pub-id pub-id-type="pmid">24251971</pub-id>
                    <issn>1351-8216</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <label>10. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Dilley</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Drews</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Miller</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lally</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Austin</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ramaswamy</surname>
                     <given-names>D</given-names>
                  </name>
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia</article-title>. 
                    <source>Obstet Gynecol</source>. 
                    <year>2001</year>
                    <month>Apr</month>;
                    <volume>97</volume>(
                    <issue>4</issue>):
                    <fpage>630</fpage>–
                    <lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">11275041</pub-id>
                    <issn>0029-7844</issn>
                </mixed-citation>
         </ref>
         <ref id="b11">
            <label>11. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>DeLoughery</surname>
                     <given-names>TG</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Microcytic anemia</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2014</year>
                    <month>Oct</month>;
                    <volume>371</volume>(
                    <issue>14</issue>):
                    <fpage>1324</fpage>–
                    <lpage>31</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMra1215361</pub-id>
                    <pub-id pub-id-type="pmid">25271605</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b12">
            <label>12. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Johnson-Wimbley</surname>
                     <given-names>TD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Graham</surname>
                     <given-names>DY</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Diagnosis and management of iron deficiency anemia in the 21st century</article-title>. 
                    <source>Therap Adv Gastroenterol</source>. 
                    <year>2011</year>
                    <month>May</month>;
                    <volume>4</volume>(
                    <issue>3</issue>):
                    <fpage>177</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/1756283X11398736</pub-id>
                    <pub-id pub-id-type="pmid">21694802</pub-id>
                    <issn>1756-283X</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <label>13. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bermejo</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>García-López</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases</article-title>. 
                    <source>World J Gastroenterol</source>. 
                    <year>2009</year>
                    <month>Oct</month>;
                    <volume>15</volume>(
                    <issue>37</issue>):
                    <fpage>4638</fpage>–
                    <lpage>43</lpage>. 
                    <pub-id pub-id-type="doi">10.3748/wjg.15.4638</pub-id>
                    <pub-id pub-id-type="pmid">19787826</pub-id>
                    <issn>1007-9327</issn>
                </mixed-citation>
         </ref>
         <ref id="b14">
            <label>14. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Todorova</surname>
                     <given-names>B</given-names>
                  </name>
                    </person-group>. 
                    <source>Talasemije v Sloveniji</source>.
                    <year>2014</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-01-10">cited 2017 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.hematologija.org/admin/files/news/pics/file/Todorova%20B%20p2014.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b15">
            <label>15. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Nuchprayoon</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sukthawee</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Nuchprayoon</surname>
                     <given-names>T</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Red cell indices and therapeutic trial of iron in diagnostic work-up for anemic Thai females</article-title>. 
                    <source>J Med Assoc Thai</source>. 
                    <year>2003</year>
                    <month>Jun</month>;
                    <volume>86</volume>
                    <supplement>Suppl 2</supplement>:
                    <fpage>S160</fpage>–
                    <lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">12929984</pub-id>
                    <issn>0125-2208</issn>
                </mixed-citation>
         </ref>
         <ref id="b16">
            <label>16. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Körber</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wölfler</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Neubauer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Robier</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Short Communication Red blood cell morphology in patients with β-thalassemia minor</article-title>. 
                    <source>J Lab Med</source>.
                    <year>2016</year>;
                    <volume>41</volume>(
                    <issue>1</issue>):
                    <fpage>49</fpage>–
                    <lpage>52</lpage>.
                    <pub-id pub-id-type="doi">10.1515/labmed-2016-0052</pub-id>
                    <issn>2567-9430 </issn>  
                </mixed-citation>
         </ref>
         <ref id="b17">
            <label>17. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Ganz</surname>
                     <given-names>T</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Hepcidin and iron regulation, 10 years later</article-title>. 
                    <source>Blood</source>. 
                    <year>2011</year>
                    <month>Apr</month>;
                    <volume>117</volume>(
                    <issue>17</issue>):
                    <fpage>4425</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2011-01-258467</pub-id>
                    <pub-id pub-id-type="pmid">21346250</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <label>18. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Locatelli</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aljama</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bárány</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canaud</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Carrera</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eckardt</surname>
                     <given-names>KU</given-names>
                  </name>
                        <etal>et al</etal>; 
                        <collab>European Best Practice Guidelines Working Group</collab>
                    </person-group>. 
                    <article-title>Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure</article-title>. 
                    <source>Nephrol Dial Transplant</source>. 
                    <year>2004</year>
                    <month>May</month>;
                    <volume>19</volume>
                    <supplement>Suppl 2</supplement>:
                    <fpage>ii1</fpage>–
                    <lpage>47</lpage>.
                    <pub-id pub-id-type="pmid">15206425</pub-id>
                    <issn>0931-0509</issn>
                </mixed-citation>
         </ref>
         <ref id="b19">
            <label>19. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Thomas</surname>
                     <given-names>DW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hinchliffe</surname>
                     <given-names>RF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Briggs</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Macdougall</surname>
                     <given-names>IC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Littlewood</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cavill</surname>
                     <given-names>I</given-names>
                  </name>; 
                        <collab>British Committee for Standards in Haematology</collab>
                    </person-group>. 
                    <article-title>Guideline for the laboratory diagnosis of functional iron deficiency</article-title>. 
                    <source>Br J Haematol</source>. 
                    <year>2013</year>
                    <month>Jun</month>;
                    <volume>161</volume>(
                    <issue>5</issue>):
                    <fpage>639</fpage>–
                    <lpage>48</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/bjh.12311</pub-id>
                    <pub-id pub-id-type="pmid">23573815</pub-id>
                    <issn>0007-1048</issn>
                </mixed-citation>
         </ref>
         <ref id="b20">
            <label>20. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Hershko</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Camaschella</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>How I treat unexplained refractory iron deficiency anemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2014</year>
                    <month>Jan</month>;
                    <volume>123</volume>(
                    <issue>3</issue>):
                    <fpage>326</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2013-10-512624</pub-id>
                    <pub-id pub-id-type="pmid">24215034</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
         </ref>
         <ref id="b21">
            <label>21. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Sinniah</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Doggart</surname>
                     <given-names>JR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Neill</surname>
                     <given-names>DW</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Diurnal variations of the serum iron in normal subjects and in patients with haemochromatosis</article-title>. 
                    <source>Br J Haematol</source>. 
                    <year>1969</year>
                    <month>Oct</month>;
                    <volume>17</volume>(
                    <issue>4</issue>):
                    <fpage>351</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1365-2141.1969.tb01381.x</pub-id>
                    <pub-id pub-id-type="pmid">5346408</pub-id>
                    <issn>0007-1048</issn>
                </mixed-citation>
         </ref>
         <ref id="b22">
            <label>22. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Skopec</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zver</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Reaktivne spremembe krvne slike in osnove zdravljenja anemije zaradi pomanjkanja železa</article-title>. 
                    <source>Zdrav Vestn</source>. 
                    <year>2008</year>;
                    <volume>77</volume>(
                    <issue>1</issue>):
                    <fpage>161</fpage>–
                    <lpage>5</lpage>.
                    <issn>0350-0063</issn>
                </mixed-citation>
         </ref>
         <ref id="b23">
            <label>23. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Akan</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Güven</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aydogdu</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Arat</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Beksaç</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dalva</surname>
                     <given-names>K</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis</article-title>. 
                    <source>Acta Haematol</source>. 
                    <year>2000</year>;
                    <volume>103</volume>(
                    <issue>3</issue>):
                    <fpage>152</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000041038</pub-id>
                    <pub-id pub-id-type="pmid">10940653</pub-id>
                    <issn>0001-5792</issn>
                </mixed-citation>
         </ref>
         <ref id="b24">
            <label>24. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bleeker</surname>
                     <given-names>JS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hogan</surname>
                     <given-names>WJ</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies</article-title>. 
                    <source>Thrombosis</source>. 
                    <year>2011</year>;
                    <volume>2011</volume>:
                    <fpage>536062</fpage>. 
                    <pub-id pub-id-type="doi">10.1155/2011/536062</pub-id>
                    <pub-id pub-id-type="pmid">22084665</pub-id>
                    <issn>2090-1488</issn>
                </mixed-citation>
         </ref>
         <ref id="b25">
            <label>25. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lim</surname>
                     <given-names>Y</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lee</surname>
                     <given-names>EY</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Choi</surname>
                     <given-names>IS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>TY</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Yoon</surname>
                     <given-names>SS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>KH</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Leukopenia in patients with iron deficiency anemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2011</year>;
                    <volume>118</volume>(
                    <issue>21</issue>):
                    <fpage>5279</fpage>.
                    <issn>0006-4971</issn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <label>26. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lima</surname>
                     <given-names>CS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Paula</surname>
                     <given-names>EV</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Takahashi</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saad</surname>
                     <given-names>ST</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lorand-Metze</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Costa</surname>
                     <given-names>FF</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Causes of incidental neutropenia in adulthood</article-title>. 
                    <source>Ann Hematol</source>. 
                    <year>2006</year>
                    <month>Oct</month>;
                    <volume>85</volume>(
                    <issue>10</issue>):
                    <fpage>705</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00277-006-0150-0</pub-id>
                    <pub-id pub-id-type="pmid">16807747</pub-id>
                    <issn>0939-5555</issn>
                </mixed-citation>
         </ref>
         <ref id="b27">
            <label>27. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lopas</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rabiner</surname>
                     <given-names>SF</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Thrombocytopenia associated with iron deficiency anemia. A report of five cases</article-title>. 
                    <source>Clin Pediatr (Phila)</source>. 
                    <year>1966</year>
                    <month>Oct</month>;
                    <volume>5</volume>(
                    <issue>10</issue>):
                    <fpage>609</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/000992286600501008</pub-id>
                    <pub-id pub-id-type="pmid">5926915</pub-id>
                    <issn>0009-9228</issn>
                </mixed-citation>
         </ref>
         <ref id="b28">
            <label>28. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Morris</surname>
                     <given-names>VK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Spraker</surname>
                     <given-names>HL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Howard</surname>
                     <given-names>SC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ware</surname>
                     <given-names>RE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Reiss</surname>
                     <given-names>UM</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Severe thrombocytopenia with iron deficiency anemia</article-title>. 
                    <source>Pediatr Hematol Oncol</source>. 
                    <year>2010</year>
                    <month>Aug</month>;
                    <volume>27</volume>(
                    <issue>5</issue>):
                    <fpage>413</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/08880011003739455</pub-id>
                    <pub-id pub-id-type="pmid">20670168</pub-id>
                    <issn>0888-0018</issn>
                </mixed-citation>
         </ref>
         <ref id="b29">
            <label>29. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Ganti</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Shonka</surname>
                     <given-names>NA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Haire</surname>
                     <given-names>WD</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Pancytopenia due to iron deficiency worsened by iron infusion: a case report</article-title>. 
                    <source>J Med Case Reports</source>. 
                    <year>2007</year>
                    <month>Dec</month>;
                    <volume>1</volume>(
                    <issue>1</issue>):
                    <fpage>175</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/1752-1947-1-175</pub-id>
                    <pub-id pub-id-type="pmid">18067664</pub-id>
                    <issn>1752-1947</issn>
                </mixed-citation>
         </ref>
         <ref id="b30">
            <label>30. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Das Makheja</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kumar Maheshwari</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Arain</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kumar</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kumari</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vikash</surname>
                  </name>
                    </person-group>. 
                    <article-title>The common causes leading to pancytopenia in patients presenting to tertiary care hospital</article-title>. 
                    <source>Pak J Med Sci</source>. 
                    <year>2013</year>
                    <month>Sep</month>;
                    <volume>29</volume>(
                    <issue>5</issue>):
                    <fpage>1108</fpage>–
                    <lpage>11</lpage>.
                    <pub-id pub-id-type="pmid">24353701</pub-id>
                    <issn>1682-024X</issn>
                </mixed-citation>
         </ref>
         <ref id="b31">
            <label>31. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Andrews</surname>
                     <given-names>NC</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Iron metabolism: iron deficiency and iron overload</article-title>. 
                    <source>Annu Rev Genomics Hum Genet</source>. 
                    <year>2000</year>;
                    <volume>1</volume>(
                    <issue>1</issue>):
                    <fpage>75</fpage>–
                    <lpage>98</lpage>. 
                    <pub-id pub-id-type="doi">10.1146/annurev.genom.1.1.75</pub-id>
                    <pub-id pub-id-type="pmid">11701625</pub-id>
                    <issn>1527-8204</issn>
                </mixed-citation>
         </ref>
         <ref id="b32">
            <label>32. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Andoljšek</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>
                    <chapter-title>Bolezni krvi in krvotvornih organov</chapter-title>. In:
                    <person-group person-group-type="author">
                    <name name-style="western">
                     <surname>Kocijančič</surname>
                     <given-names>A</given-names>
                  </name>,
                     <name name-style="western">
                     <surname>Mrelje</surname>
                     <given-names>V</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Štajer</surname>
                     <given-names>D</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>černelč</surname>
                     <given-names>P</given-names>
                  </name>, 
                    <role>eds</role>
                    </person-group>. 
                    <source>Interna medicina</source>. 
                    <edition>3rd ed</edition>.
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Littera picta</publisher-name>;
                    <year>2011</year>.pp. 
                    <fpage>1243</fpage>–
                    <lpage>393</lpage>.
                </mixed-citation>
         </ref>
         <ref id="b33">
            <label>33. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zijp</surname>
                     <given-names>IM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korver</surname>
                     <given-names>O</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tijburg</surname>
                     <given-names>LB</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Effect of tea and other dietary factors on iron absorption</article-title>. 
                    <source>Crit Rev Food Sci Nutr</source>. 
                    <year>2000</year>
                    <month>Sep</month>;
                    <volume>40</volume>(
                    <issue>5</issue>):
                    <fpage>371</fpage>–
                    <lpage>98</lpage>. 
                    <pub-id pub-id-type="doi">10.1080/10408690091189194</pub-id>
                    <pub-id pub-id-type="pmid">11029010</pub-id>
                    <issn>1040-8398</issn>
                </mixed-citation>
         </ref>
         <ref id="b34">
            <label>34. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Marignani</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Angeletti</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bordi</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Malagnino</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mancino</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Delle Fave</surname>
                     <given-names>G</given-names>
                  </name>
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection</article-title>. 
                    <source>Scand J Gastroenterol</source>. 
                    <year>1997</year>
                    <month>Jun</month>;
                    <volume>32</volume>(
                    <issue>6</issue>):
                    <fpage>617</fpage>–
                    <lpage>22</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/00365529709025109</pub-id>
                    <pub-id pub-id-type="pmid">9200297</pub-id>
                    <issn>0036-5521</issn>
                </mixed-citation>
         </ref>
         <ref id="b35">
            <label>35. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Nairz</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schroll</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sonnweber</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Weiss</surname>
                     <given-names>G</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The struggle for iron - a metal at the host-pathogen interface</article-title>. 
                    <source>Cell Microbiol</source>. 
                    <year>2010</year>
                    <month>Dec</month>;
                    <volume>12</volume>(
                    <issue>12</issue>):
                    <fpage>1691</fpage>–
                    <lpage>702</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01529.x</pub-id>
                    <pub-id pub-id-type="pmid">20964797</pub-id>
                    <issn>1462-5814</issn>
                </mixed-citation>
         </ref>
         <ref id="b36">
            <label>36. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zager</surname>
                     <given-names>RA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>AC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hanson</surname>
                     <given-names>SY</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Parenteral iron therapy exacerbates experimental sepsis</article-title>. 
                    <source>Kidney Int</source>. 
                    <year>2004</year>
                    <month>Jun</month>;
                    <volume>65</volume>(
                    <issue>6</issue>):
                    <fpage>2108</fpage>–
                    <lpage>12</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00742.x</pub-id>
                    <pub-id pub-id-type="pmid">15149323</pub-id>
                    <issn>0085-2538</issn>
                </mixed-citation>
         </ref>
         <ref id="b37">
            <label>37. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Moretti</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goede</surname>
                     <given-names>JS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zeder</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jiskra</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chatzinakou</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tjalsma</surname>
                     <given-names>H</given-names>
                  </name>
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women</article-title>. 
                    <source>Blood</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>126</volume>(
                    <issue>17</issue>):
                    <fpage>1981</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2015-05-642223</pub-id>
                    <pub-id pub-id-type="pmid">26289639</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
         </ref>
         <ref id="b38">
            <label>38. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Schrier</surname>
                     <given-names>SL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>So you know how to treat iron deficiency anemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>126</volume>(
                    <issue>17</issue>):
                    <fpage>1971</fpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2015-09-666511</pub-id>
                    <pub-id pub-id-type="pmid">26494915</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
         </ref>
         <ref id="b39">
            <label>39. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bircher</surname>
                     <given-names>AJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Auerbach</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Hypersensitivity from intravenous iron products</article-title>. 
                    <source>Immunol Allergy Clin North Am</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>34</volume>(
                    <issue>3</issue>):
                    <fpage>707</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.iac.2014.04.013</pub-id>
                    <pub-id pub-id-type="pmid">25017687</pub-id>
                    <issn>0889-8561</issn>
                </mixed-citation>
         </ref>
         <ref id="b40">
            <label>40. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Rampton</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Folkersen</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fishbane</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hedenus</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Howaldt</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Locatelli</surname>
                     <given-names>F</given-names>
                  </name>
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management</article-title>. 
                    <source>Haematologica</source>. 
                    <year>2014</year>
                    <month>Nov</month>;
                    <volume>99</volume>(
                    <issue>11</issue>):
                    <fpage>1671</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.3324/haematol.2014.111492</pub-id>
                    <pub-id pub-id-type="pmid">25420283</pub-id>
                    <issn>0390-6078</issn>
                </mixed-citation>
         </ref>
         <ref id="b41">
            <label>41. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Carson</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Strair</surname>
                     <given-names>R</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Transfusion strategies in hematologic and nonhematologic disease</article-title>. 
                    <source>Hematology (Am Soc Hematol Educ Program)</source>. 
                    <year>2014</year>
                    <month>Dec</month>;
                    <volume>2014</volume>(
                    <issue>1</issue>):
                    <fpage>548</fpage>–
                    <lpage>52</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/asheducation-2014.1.548</pub-id>
                    <pub-id pub-id-type="pmid">25696909</pub-id>
                    <issn>1520-4391</issn>
                </mixed-citation>
         </ref>
         <ref id="b42">
            <label>42. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Goddard</surname>
                     <given-names>AF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>James</surname>
                     <given-names>MW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>McIntyre</surname>
                     <given-names>AS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Scott</surname>
                     <given-names>BB</given-names>
                  </name>; 
                        <collab>British Society of Gastroenterology</collab>
                    </person-group>. 
                    <article-title>Guidelines for the management of iron deficiency anaemia</article-title>. 
                    <source>Gut</source>. 
                    <year>2011</year>
                    <month>Oct</month>;
                    <volume>60</volume>(
                    <issue>10</issue>):
                    <fpage>1309</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/gut.2010.228874</pub-id>
                    <pub-id pub-id-type="pmid">21561874</pub-id>
                    <issn>0017-5749</issn>
                </mixed-citation>
         </ref>
         <ref id="b43">
            <label>43. </label>
            <mixed-citation publication-type="webpage">
                    <source>Centralna baza zdravil 2</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-01-11">cited 2017 Jan 11</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&amp;Query=(%5BSEZNAMUCINKNAZIV%5D=_%C5%BEelezo*)&amp;SearchOrder=4&amp;SearchMax=301</uri>
               </comment>.
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
